History of Coccidioidomycosis: “Dust to Dust”

  • Stanley C. Deresinski
Part of the Current Topics in Infectious Disease book series (CTID)

Abstract

In the tumult following Pearl Harbor, tens of thousands of persons of Japanese ancestry in the United States were placed in camps throughout the country as part of the infamous World War II policy of “internment.” Among the locations used was one on the Gila River in the desert of southern Arizona. Since this area was known to be endemic for coccidioidomycosis, there was little surprise when many cases of the disease appeared among the unwilling residents of the camp.

Keywords

Transfer Factor Mycosis Fungoides Methyl Violet Tuberculous Pleural Effusion Kern County 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    C. E. Smith, Coccidioidomycosis, in: Preventive Medicine in World War II, Vol. IV, Communicable Diseases Transmitted Chiefly Through the Respiratory and Alimentary Tracts (E. C. Hoff, ed.), Department of the Army, Washington, D.C., U.S. Government Printing Office (1958), pp. 285–316.Google Scholar
  2. 2.
    A. Posadas, Un nuevo caso de micosis fungoidea con psorospermias, An. Circ. Med. Argent. 15: 585–597 (1892).Google Scholar
  3. 3.
    R. Wernicke, Ueber einen protozoenbefund bei Mycosis fungoides Zentrabl. Bakteriol. 12: 859–861 (1892).Google Scholar
  4. 4.
    E. Rixford, Early history of coccidioidal granuloma in California, in: Coccidioidal Granuloma, Calif. State Dep. Public Health Spec. Bull. No. 57 (1931), pp. 5–8.Google Scholar
  5. 5.
    E. Rixford and T. C. Gilchrist, Two cases of protozoan (coccidioidal) infection of the skin and other organs, Johns Hopkins Hosp. Rep. 1:209–268 (18%).Google Scholar
  6. 6.
    W. S. Thorne, A case of protozoic skin disease, Occident. Med. Times 8: 703–704 (1894).Google Scholar
  7. 7.
    E. Rixford, A case of protozoic dermatitis, Occident. Med. Times 8: 704–707 (1894).Google Scholar
  8. 8.
    W. Ophuls and H. C. Moffitt, A new pathogenic mould (formerly described as a protozoan: Coccidioides immitis pyogenes). Preliminary Report, Philadel. Med. J. 5: 1471–1472 (1900).Google Scholar
  9. 9.
    W. Ophuls, Further observations on a pathogenic mould formerly described as a protozoan (Coccidioides immitis, Coccidioides pyogenes), J. Exp. Med. 6: 443–486 (1905).PubMedCrossRefGoogle Scholar
  10. 10.
    W. Ophuls, Coccidioidal granuloma, J. Am. Med. Assoc. 45: 1201–1296 (1905).Google Scholar
  11. 11.
    C. E. Smith, Reminiscences of the flying chlamydospore and its allies, in: Coccidioidomycosis (L. Ajello, ed.), University of Arizona Press, Tucson (1967) pp. xiii-xxii.Google Scholar
  12. 12.
    E. C. Dickson, “Valley Fever” of the San Joaquin Valley and fungus Coccidioides, Calif. West. Med. 47: 151–155 (1937).Google Scholar
  13. 13.
    R. A. Stewart and K. F. Meyer, Isolation of Coccidioides immitis from soil, Proc. Soc. Exp. Biol. Med. 29: 937–938, 1932.Google Scholar
  14. 14.
    M. A. Gifford, San Joaquin fever, in: Kern County Health Department Annual Report (1935–1936), pp. 22–23.Google Scholar
  15. 15.
    M. A. Gifford, W. C. Buss, and R. J. Dowds, Data on Coccidioides fungus infection, Kern County, 1901–1936, in: Kern County Health Department Annual Report (1936–1937), pp. 39–54.Google Scholar
  16. 16.
    J. V. Cooke, Immunity tests in coccidioidal granuloma, Proc. Soc. Exp. Biol. Med. 12: 35 (1914).Google Scholar
  17. 17.
    D. J. Davis, Coccidioidal granuloma with certain serologic and experimental observations, Arch. Dermatol. Syphilol. 9: 577–588 (1924).CrossRefGoogle Scholar
  18. 18.
    C. E. Smith, R. R. Beard, E. G. Whiting, and H. G. Rosenberger, Varieties of coccidioidal infection in relation to the epidemiology and control of the disease, Am. J. Public Health 36: 1394–1402 (1946).CrossRefGoogle Scholar
  19. 19.
    C. E. Smith, E. G. Whiting, E. E. Baker, H. G. Rosenberger, R. R. Beard, and M. T. Saito, The use of coccidioidin, Am. Rev. Tuberc. 57: 330–360 (1948).PubMedGoogle Scholar
  20. 20.
    C. E. Smith, M. T. Saito, and S. A Simmons, Pattern of 39,500 serologic tests in coccidioidomycosis, J. Am. Med. Assoc. 160: 546–552 (1956).PubMedCrossRefGoogle Scholar
  21. 21.
    K. T. Maddy, The geographic distribution of Coccidioides immitis and possible ecologic implications, Ariz. Med. 15: 178–188 (1958).PubMedGoogle Scholar
  22. 22.
    C. H. Merriam, Results of a biological survey of the San Francisco mountain region and desert of the little Colorado in Arizona, in: North American Fauna, No. 3, U.S. Department of Agriculture (1890), pp. 1–34.Google Scholar
  23. 23.
    M. Silverman, The mystery of the deadly dust, Saturday Evening Post, December 17, 1949.Google Scholar
  24. 24.
    P. Negroni, D. Vivoli, and H. Bonfliglioli, Estudios sobre el Coccidioides immitis Rixford y Gilchrist. VII. Reacciones immunoalergicas en la infección experimental del cobayo, Rev. Inst. Bacteriol. Dep. Nac. Hig. (Argent.) 14: 273–286 (1949).Google Scholar
  25. 25.
    C. E. Smith, Annual Progress Report, Commission on Acute Respiratory Diseases, Armed Forces Epidemiological Board, Washington, D.C. (1951).Google Scholar
  26. 26.
    L. Friedman and C. E. Smith, Vaccination of mice against Coccidioides immitis, Am. Rev. Tuberc. 74: 245–248 (1956).PubMedGoogle Scholar
  27. 27.
    D. Pappagianis, H. B. Levine, C. E. Smith, R. J. Berman, and G. S. Kobayashi, Immunization of mice with viable Coccidioides immitis, J. Immunol. 86: 28–34 (1961).PubMedGoogle Scholar
  28. 28.
    J. L. Converse, M. W. Castleberry, A. R. Besemer, and E. M. Synder, Immunization of mice against coccidioidomycosis, J. Bacteriol. 84: 46–52 (1962).PubMedGoogle Scholar
  29. 29.
    R. A. Vogel, B. F. Fetter, N. F. Conant, and E. P. Lowe, Preliminary studies on artificial active immunization of guinea pigs against respiratory challenge of Coccidioides immitis, Am. Rev. Tuberc. 70: 498–503 (1954).PubMedGoogle Scholar
  30. 30.
    H. B. Levine, J. M. Cobb, and C. E. Smith, Immunity to coccidioidomycosis induced in mice by purified spherule, arthrospore and mycelial vaccines, Trans. N.Y. Acad. Sci. II 22: 436–449 (1960).CrossRefGoogle Scholar
  31. 31.
    H. B. Levine, R. L. Miller, and C. E. Smith, Influence of vaccination on respiratory coccidioidal disease in cynomolgous monkeys, J. Immunol. 89: 242–251 (1962).PubMedGoogle Scholar
  32. 32.
    H. B. Levine, J. M. Cobb, and C. E. Smith, Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice, J. Immunol. 87: 218–219 (1961).PubMedGoogle Scholar
  33. 33.
    P. Broughton, A special kind of immortality, Am. J. Public Health 57: 1087–1090 (1967).CrossRefGoogle Scholar
  34. 34.
    D. Pappagianis and H. B. Levine, The present status of vaccination against coccidioidomycosis in man, Am. J. Epidemiol. 102: 30–41 (1975).PubMedGoogle Scholar
  35. 35.
    J. L. Converse, Growth of spherules of Coccidioides immitis in a chemically defined liquid medium, Proc. Soc. Exp. Biol. Med. 90: 709–711 (1955).PubMedGoogle Scholar
  36. 36.
    H. B. Levine, J. M. Cobb, and G. M. Scalarone, Spherule coccidioidin in delayed dermal sensitivity reactions of experimental animals, Sabouraudia 7: 20–32 (1969).PubMedCrossRefGoogle Scholar
  37. 37.
    D. A. Stevens, H. B. Levine, and D. R. Ten Eyck, Dermal sensitivity to different doses of spherulin and coccidioidin, Chest 65: 530–533 (1974).PubMedCrossRefGoogle Scholar
  38. 38.
    D. A. Stevens, H. B. Levine, S. C. Deresinski, and L. J. Blaine, Spherulin in clinical coccidioidomycosis-comparison with coccidioidin, Chest 68: 697–702 (1975).CrossRefGoogle Scholar
  39. 39.
    M. J. Fiese, Coccidioidomycosis, Charles C. Thomas, Springfield, Ill. (1958).Google Scholar
  40. 40.
    W. A. Winn, The treatment of coccidioidal meningitis-the use of amphotericin B in a group of 25 patients, Calif. Med. 10: 78–89 (1964).Google Scholar
  41. 41.
    W. A. Winn, Coccidioidomycosis and amphotericin B, Med. Clin. North Am. 47: 1131–1148 (1963).PubMedGoogle Scholar
  42. 42.
    W. D. Forbus and A. M. Bestebreurtje, Coccidioidomycosis: a study of 95 cases of the disseminated type with special reference to the pathogenesis of the disease, Mil. Surg. 99: 653–719 (1946).PubMedGoogle Scholar
  43. 43.
    F. T. Rappaport, H. S. Lawrence, J. W. Miller, D. Pappagianis, and C. E. Smith, Transfer of delayed hypersensitivity to coccidioidin in man, J. Immunol. 84: 358–367 (1960).Google Scholar
  44. 44.
    A. Catanzaro. L. E. Spitler, and K. M. Moser, Cellular immune response in coccidioidomycosis Cell. Immunol. 15: 360–371 (1975).PubMedCrossRefGoogle Scholar
  45. 45.
    J. R. Graybill, J. Silva, Jr., R. H. Alford, D. E. Thor, Immunologic and clinical improvement of progressive coccidioidomycosis following administration of transfer factor, Cell. Immunol. 8: 120–135 (1973).PubMedCrossRefGoogle Scholar
  46. 46.
    P. Cloninger, L. D. Thrupp, G. A. Granger, and H. S. Novey, Immunotherapy with transfer factor in disseminated coccidioidal osteomyelitis and arthritis, West. J. Med. 120: 322–325 (1974).PubMedGoogle Scholar
  47. 47.
    D. A. Stevens, D. Pappagianis, V. A. Marinkovich, and T. F. Waddell, Immunotherapy in recurrent coccidioidomycosis, Cell. Immunol. 12: 37–48 (1974).PubMedCrossRefGoogle Scholar
  48. 48.
    A. Catanzaro, L. Spitler, K. M. Moser, Immunotherapy of coccidioidomycosis, J. Clin. Invest. 54: 690–701 (1974).PubMedCrossRefGoogle Scholar
  49. 49.
    J. R. Graybill (for the Coccidioidomycosis Cooperative Treatment Group), The clinical course of coccidioidomycosis following transfer factor therapy, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami (1977), pp. 335–345.Google Scholar
  50. 50.
    D. A. Stevens, Miconazole in the treatment of systemic fungal infections, Am. Rev. Resp. Dis. 116: 801–806 (1977).PubMedGoogle Scholar
  51. 51.
    H. B. Levine, S. M. Ringel, and J. M. Cobb, Therapeutic properties of oral ambruticin (W7783) in experimental pulmonary coccidioidomycosis of mice, Chest 73: 202–206 (1978).PubMedCrossRefGoogle Scholar
  52. 52.
    D. Borelli, J. L. Bran, J. Fuentes, R. Legendre, E. Leiderman, H. B. Levine, A. Restrepo-M., and D. A. Stevens, Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs, Postgrad. Med. J. 55: 657–661 (1979).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1980

Authors and Affiliations

  • Stanley C. Deresinski

There are no affiliations available

Personalised recommendations